Results 131 to 140 of about 12,022 (202)

Mitigation and management of adverse events associated with amivantamab therapy. [PDF]

open access: yesOncologist
Florez N   +13 more
europepmc   +1 more source

Anifrolumab for refractory chilblain lupus erythematosus. [PDF]

open access: yesInt J Womens Dermatol
Bulosan H   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy